Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Filing Details Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 16, 2026. The Healthcare…
Read moreFiling Details FASTENAL CO (NASDAQ:FAST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 16, 2026. The Industrials company reported Q0…
Read moreFiling Details Main Street Capital CORP (NYSE:MAIN) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event. Market Context Main…
Read moreFiling Details GameSquare Holdings, Inc. (NASDAQ:GAME) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 16, 2026. The Technology…
Read moreFiling Details GENERAL ELECTRIC CO (NYSE:GE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 16, 2026. The Industrials company reported…
Read moreFiling Details COMMERCE BANCSHARES INC /MO/ (NASDAQ:CBSH) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event. Market…
Read moreFiling Details New Horizon Aircraft Ltd. (NASDAQ:HOVR) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 16, 2026. The Industrials company's…
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on RXO, Inc. (NYSE:RXO) on July 16, 2026. Market Context RXO, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on Olin Corporation (NYSE:OLN) on July 16, 2026. Market Context Olin Corporation operates in the Basic Materials…
Read moreRating Change Citigroup analysts initiated coverage on Hikma Pharmaceuticals PLC (OTC:HKMPY) with a Buy rating on July 16, 2026. Market Context Hikma Pharmaceuticals PLC operates…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Celanese Corporation (NYSE:CE) on July 16, 2026. Market Context Celanese Corporation operates in the…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Webull Corporation Class A Ordinary Shares (NASDAQ:BULL) on July 16, 2026. Market Context Webull Corporation Class A…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Noble Corporation Plc (NYSE:NE) on July 16, 2026. Market Context Noble Corporation Plc operates in the Energy…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Texas Roadhouse, Inc. (NASDAQ:TXRH) on July 16, 2026. Market Context Texas Roadhouse, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Globus Medical, Inc. (NYSE:GMED) on July 16, 2026. Market Context Globus Medical, Inc.
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on WEC Energy Group, Inc. (NYSE:WEC) on July 16, 2026. Market Context WEC Energy Group, Inc.
Read moreRating Change Truist Securities analysts reiterated a Hold rating on WEC Energy Group, Inc. (NYSE:WEC) on July 16, 2026. Market Context WEC Energy Group, Inc.
Read moreRating Change UBS analysts reiterated a Neutral rating on Kenvue Inc. (NYSE:KVUE) on July 16, 2026. Market Context Kenvue Inc.
Read moreRating Change Citigroup analysts initiated coverage on NatWest Group plc (NYSE:NWG) with a Buy rating on July 16, 2026. Market Context NatWest Group plc operates in the Financial…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Xylem Inc. (NYSE:XYL) on July 16, 2026. Market Context Xylem Inc.
Read more
